Technology area: Biotechnology & Pharmaceuticals
52 pending office actions • 19 clients • 46 examiners • 27 art units • 0 of 52 (0%) have an AI response strategy ready
Sullivan & Worcester LLP handles Biotechnology & Pharmaceuticals matters with 615 career applications and 53 pending office actions. The application history provides a substantial basis for viewing the firm’s reported prosecution activity, while the pending docket identifies current matters requiring office-action attention.
Its resolved allowance rate is 86.78%, and the average is 4.12 office actions per allowance. Taken together, those measures indicate that resolved matters have frequently reached allowance, while allowances have generally followed multiple office-action events. Counsel evaluating this record should consider both measures rather than relying on the allowance rate alone.
The combination of application volume, pending workload, and resolution metrics supports a balanced review of prosecution performance in this field. The figures describe historical and current activity, but they do not explain the claim scope, prosecution strategy, or individual technology differences behind the outcomes.
Based on the USPTO statutory response window for each pending office action. 15 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 15 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (2%) |
| §101 + other | 17 (33%) |
| §103 only | 9 (17%) |
| §102 only | 1 (2%) |
| §112 only | 3 (6%) |
| Double-patenting only | 1 (2%) |
| Double-patenting + other | 8 (15%) |
| Multi-statute (no §101) | 12 (23%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BUNKER, AMY M | 2 | 29.1% | +45.6% |
| YU, TIAN NMN | 2 | 55.6% | +19.3% |
| RAMADAN, OMAR | 2 | 25.4% | +56.5% |
| JONES, CHRISTINE MICHELLE | 2 | 0.0% | +0.0% |
| LU, FRANK WEI MIN | 2 | 62.7% | +67.9% |
| MARCETICH, ADAM M | 2 | 72.8% | +18.8% |
| ZHANG, KAIJIANG | 1 | 77.2% | +34.3% |
| FRONDA, CHRISTIAN L | 1 | 82.5% | +14.3% |
| NGUYEN, HUY TRAM | 1 | 79.3% | +6.6% |
| CABRAL, ROBERT S | 1 | 62.8% | +32.3% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19047328 | METHODS FOR PROCESSING NUCLEIC ACID SAMPLES | FRONDA, CHRISTIAN L | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17732769 | CALIBRATION OF A FUNCTIONAL BIOMARKER INSTRUMENT | JARRETT, LORE RAMILLANO | 114d overdue |
| 17729760 | SYSTEM AND METHOD FOR ISOLATING AND ANALYZING CELLS | BUNKER, AMY M | 46d overdue |
| 18204703 | DETECTION OF TARGET NUCLEIC ACIDS | GREENE, CAROLYN LEE | 43d overdue |
| 17947871 | LYMPHATIC FLUID FOR DIAGNOSTICS | MYERS, CARLA J | 30d overdue |
| 17403811 | CATHETER SYSTEMS AND RELATED METHODS FOR MAPPING, MINIMIZING, AND TREATING CARDIAC FIBRILLATION | LEE, DAVINA EN-YIN | 1d overdue |
| 18266404 | COMPOSITIONS AND METHODS FOR DETECTING AND TREATING ORAL CAVITY SQUAMOUS CELL CARCINOMA | BAUSCH, SARAE L | 12d |
| 16739814 | MACHINE LEARNING IN FUNCTIONAL CANCER ASSAYS | COLEMAN, CHARLES P. | 15d |
| 17947861 | METHODS FOR DISEASE ASSESSMENT USING DRAIN FLUID | PAGUIO FRISING, MICHELLE F | 22d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17729760 | SYSTEM AND METHOD FOR ISOLATING AND ANALYZING CELLS | BUNKER, AMY M | 46d overdue |
| 18087165 | METHODS FOR CANCER TREATMENT | MARCETICH, ADAM M | 5d |
| 17466309 | DISTINGUISHING RARE VARIATIONS IN A NUCLEIC ACID SEQUENCE FROM A SAMPLE | YU, TIAN NMN | 47d |
| 19361770 | COMPOSITIONS AND METHODS FOR MOLECULAR LABELING | ZHANG, KAIJIANG | — |
| 19047328 | METHODS FOR PROCESSING NUCLEIC ACID SAMPLES | FRONDA, CHRISTIAN L | — |
| 18913441 | Compositions of Hypochlorous Acid (HOCL) and Methods Of Manufacture Thereof | CABRAL, ROBERT S | — |
| 18778205 | DEVICES AND METHODS FOR mtDNA EXTRACTION | BUNKER, AMY M | — |
| 18666949 | LINKAGE ASSAY | YU, TIAN NMN | — |
| Art Unit | Apps |
|---|---|
| 1681 | 8 |
| 1682 | 5 |
| 1683 | 5 |
| 1684 | 3 |
| 1637 | 3 |
| 3794 | 2 |
| 1799 | 2 |
| 1678 | 2 |
| 1797 | 2 |
| 3781 | 2 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19361770 | COMPOSITIONS AND METHODS FOR MOLECULAR LABELING | BIO-RAD LABORATORIES, INC. | ZHANG, KAIJIANG | 1684 | §102Other | Non-Final OA | — | Pending | Oct 17, 2025 |
| 19047328 | METHODS FOR PROCESSING NUCLEIC ACID SAMPLES | BIO-RAD LABORATORIES, INC. | FRONDA, CHRISTIAN L | 1652 | §103§112DP | Non-Final OA | — | Pending | Feb 06, 2025 |
| 18927215 | MULTI-CHAMBER HYPOCHLOROUS ACID DISPENSER | Wiab Water Innovation AB | NGUYEN, HUY TRAM | 1774 | §101§112DP | Non-Final OA | — | Pending | Oct 25, 2024 |
| 18913441 | Compositions of Hypochlorous Acid (HOCL) and Methods Of Manufacture Thereof | Wiab Water Innovation AB | CABRAL, ROBERT S | 1614 | DP | Non-Final OA | — | Pending | Oct 11, 2024 |
| 18796943 | SATELLITE COMMUNICATION SYSTEM | Commcrete Ltd. | CHOI, WON JUN | 2411 | §103§112 | Non-Final OA | — | Pending | Aug 07, 2024 |
| 18797023 | REMOTE COMMUNICATIONS METHODS | Commcrete Ltd. | LAWRENCE, JOHN CALEB | 2646 | §103§112 | Non-Final OA | — | Pending | Aug 07, 2024 |
| 18778205 | DEVICES AND METHODS FOR mtDNA EXTRACTION | Inso Biosciences, Inc. | BUNKER, AMY M | 1684 | §102§103§112DP | Non-Final OA | — | Pending | Jul 19, 2024 |
| 18772583 | MIXING DEVICE | Wiab Water Innovation AB | BREWSTER, HAYDEN R | 1779 | §112DP | Non-Final OA | — | Pending | Jul 15, 2024 |
| 18676828 | CATHETERS, SYSTEMS, AND RELATED METHODS FOR MAPPING, MINIMIZING, AND TREATING CARDIAC FIBRILLATION | University Of Vermont And State Agricultural College | BOCK, ABIGAIL MARIE | 3794 | §103 | Final Rejection | — | Pending | May 29, 2024 |
| 18666949 | LINKAGE ASSAY | BIO-RAD LABORATORIES, INC. | YU, TIAN NMN | 1681 | §112 | Non-Final OA | — | Pending | May 17, 2024 |
| 18653326 | SURGICAL DEVICES FOR SOFT TISSUE AUGMENTATION | Expand Medical Ltd. | BYRD, BRIGID K | 3771 | §102§103§112 | Final Rejection | — | Pending | May 02, 2024 |
| 18627895 | ALGORITHMIC TECHNIQUES FOR DEDUCTION OF FUNCTIONAL CHARACTERISTICS OF CARDIAC TISSUE IN CARDIAC ELECTRICAL FIBRILLATION FROM A DENSELY PACKED ARRAY OF HIGH-RESOLUTION ELECTRODES | Coremap, Inc. | JOHNSON, NICOLE F | 3796 | §103§112Other | Final Rejection | 29d | Pending | Apr 05, 2024 |
| 18690011 | DEVICES, METHODS, AND SYSTEMS FOR EXTRACTING GENOMIC DNA FROM CELL SAMPLES WITH TUNABLE SIZE SELECTION | Inso Biosciences Inc. | YOH, JULIUS FRANCIS | 1799 | §102§103§112 | Non-Final OA | — | Pending | Mar 07, 2024 |
| 18435187 | DRAIN FLUIDS FOR DISEASE DIAGNOSIS AND MONITORING | Droplet Biosciences, Inc. | PRIEST, AARON A | 1681 | §102§103 | Non-Final OA | — | Pending | Feb 07, 2024 |
| 18580444 | COMPOSITIONS AND METHODS FOR DETECTION OF COLORECTAL CANCER | Mercy Bioanalytics, Inc. | HANEY, AMANDA MARIE | 1682 | §101§102§103§112DP | Non-Final OA | — | Pending | Jan 18, 2024 |
| 18580422 | COMPOSITIONS AND METHODS FOR DETECTION OF LIVER CANCER | Mercy Bioanalytics, Inc. | KIM, YOUNG J | 1681 | §101§112 | Final Rejection | 33d | Pending | Jan 18, 2024 |
| 18580427 | COMPOSITIONS AND METHODS FOR DETECTION OF BREAST CANCER | Mercy Bioanalytics, Inc. | CASH, KAILEY ELIZABETH | 1683 | §101§103§112DP | Non-Final OA | — | Pending | Jan 18, 2024 |
| 18580412 | COMPOSITIONS AND METHODS FOR DETECTION OF PANCREATIC CANCER | Mercy Bioanalytics, Inc. | DAUNER, JOSEPH G | 1682 | §101§103§112DP | Non-Final OA | — | Pending | Jan 18, 2024 |
| 18580440 | COMPOSITIONS AND METHODS FOR DETECTION OF ESOPHAGEAL CANCER | Mercy Bioanalytics, Inc. | WOOLWINE, SAMUEL C | 1681 | §112 | Final Rejection | — | Pending | Jan 18, 2024 |
| 18542057 | ANALYSIS OF EFFLUENT | Droplet Biosciences, Inc. | RAMADAN, OMAR | 1678 | §101§102§103§112 | Non-Final OA | — | Pending | Dec 15, 2023 |
| 18542193 | ANALYSIS OF EFFLUENT | Droplet Biosciences, Inc. | JONES, CHRISTINE MICHELLE | 1682 | §101§102§103§112 | Final Rejection | — | Pending | Dec 15, 2023 |
| 18538076 | DIGITAL ANALYSIS OF NUCLEIC ACID MODIFICATION | BIO-RAD LABORATORIES, INC. | LU, FRANK WEI MIN | 1683 | §102§112 | Non-Final OA | — | Pending | Dec 13, 2023 |
| 18557630 | THERAPEUTIC COMPOSITIONS FOR TREATING PAIN VIA MULTIPLE TARGETS | Quiver Holdings Inc. | ZARA, JANE J | 1637 | §102§112DP | Non-Final OA | — | Pending | Oct 27, 2023 |
| 18242658 | SYSTEM AND METHOD FOR LEAKAGE CONTROL IN A PARTICLE CAPTURE SYSTEM | BIO-RAD LABORATORIES, INC. | CROW, ROBERT THOMAS | 1683 | §103§112DP | Non-Final OA | — | Pending | Sep 06, 2023 |
| 18240445 | STRUCTURAL VARIANT IDENTIFICATION | Saga Diagnostics AB | FONSECA LOPEZ, FRANCINI ALVARENGA | 1685 | §101§102§103§112 | Non-Final OA | — | Pending | Aug 31, 2023 |
| 18240416 | MULTI-VECTOR DETECTION OF VARIANT SEQUENCES | Saga Diagnostics AB | KALLAL, ROBERT JAMES | 1683 | §101§103§112 | Non-Final OA | — | Pending | Aug 31, 2023 |
| 18240453 | DETECTION OF VARIANT ESR1 SEQUENCES | Saga Diagnostics AB | JONES, CHRISTINE MICHELLE | 1682 | §103§112DP | Non-Final OA | — | Pending | Aug 31, 2023 |
| 18347377 | TISSUE CHAMBER | Applikate Technologies, Inc. | WASHINGTON, BRITNEY NICOLE | 1797 | §102§103 | Final Rejection | 71d | Pending | Jul 05, 2023 |
| 18336198 | SCREENING FOR STRUCTURAL VARIANTS | Molecular Loop Biosciences, Inc. | OYEYEMI, OLAYINKA A | 1681 | §112DP | Non-Final OA | — | Pending | Jun 16, 2023 |
| 18266404 | COMPOSITIONS AND METHODS FOR DETECTING AND TREATING ORAL CAVITY SQUAMOUS CELL CARCINOMA | The University of Chicago | BAUSCH, SARAE L | 1699 | §101§102§103DP | Final Rejection | 12d | Pending | Jun 10, 2023 |
| 18204703 | DETECTION OF TARGET NUCLEIC ACIDS | Saga Diagnostics AB | GREENE, CAROLYN LEE | 1681 | §102§103 | Final Rejection | 43d overdue | Pending | Jun 01, 2023 |
| 18193934 | BIOPOLYMER SYNTHESIS | Ribbon Biolabs GmbH | GRAFF, SHARON LEVINE | 1687 | §101§102§103§112 | Non-Final OA | — | Pending | Mar 31, 2023 |
| 18087165 | METHODS FOR CANCER TREATMENT | Droplet Biosciences, Inc. | MARCETICH, ADAM M | 3781 | §103 | Non-Final OA | 5d | Pending | Dec 22, 2022 |
| 18055398 | ANALYSIS OF NUCLEIC ACIDS | BIO-RAD LABORATORIES, INC. | LU, FRANK WEI MIN | 1683 | §101§102§112 | Non-Final OA | — | Pending | Nov 14, 2022 |
| 17972111 | DEVICES AND METHODS FOR NUCLEIC ACID EXTRACTION-FREE STI PATHOGEN TESTING | The Regents of the University of Colorado | CHUNDURU, SURYAPRABHA | 1681 | §103DP | Final Rejection | — | Pending | Oct 24, 2022 |
| 17934428 | THERAPEUTICS FOR HAPLOINSUFFICIENCY CONDITIONS | Quelltx, Inc. | TRAN, CHRISTINA L | 1637 | §103 | Non-Final OA | 27d | Pending | Sep 22, 2022 |
| 17947861 | METHODS FOR DISEASE ASSESSMENT USING DRAIN FLUID | The Washington University | PAGUIO FRISING, MICHELLE F | 1651 | §101DP | Non-Final OA | 22d | Pending | Sep 19, 2022 |
| 17947881 | DUAL PORT DRAIN | The Washington University | MARCETICH, ADAM M | 3781 | §103 | Non-Final OA | — | Pending | Sep 19, 2022 |
| 17947871 | LYMPHATIC FLUID FOR DIAGNOSTICS | The Washington University | MYERS, CARLA J | 1682 | §101§103§112DP | Final Rejection | 30d overdue | Pending | Sep 19, 2022 |
| 17842110 | COMPOSITIONS AND METHODS FOR AERODIGESTIVE TREATMENT | Wiab Water Innovation AB | ANTHOPOLOS, PETER | 1611 | §103 | Final Rejection | — | Pending | Jun 16, 2022 |
| 17837689 | BIOCIDAL COMPOSITIONS AND METHODS OF MAKING THE SAME | Wiab Water Innovation AB | SONG, JIANFENG | 1613 | §103 | Non-Final OA | 22d | Pending | Jun 10, 2022 |
| 17751844 | SYSTEMS AND METHODS FOR MONITORING BIOELECTRICAL ACTIVITY AND ASSESSING CONDITIONS ASSOCIATED THEREWITH | Coremap, Inc. | MARLEN, TAMMIE K | 3792 | §101§103 | Final Rejection | — | Pending | May 24, 2022 |
| 17740485 | COMPOSITIONS TARGETING SODIUM CHANNEL 1.6 | Quiver Holdings Inc. | PERSONS, JENNA L | 1637 | §112 | Non-Final OA | — | Pending | May 10, 2022 |
| 17732769 | CALIBRATION OF A FUNCTIONAL BIOMARKER INSTRUMENT | Travera, Inc. | JARRETT, LORE RAMILLANO | 1797 | §101§103§112DP | Non-Final OA | 114d overdue | Pending | Apr 29, 2022 |
| 17729760 | SYSTEM AND METHOD FOR ISOLATING AND ANALYZING CELLS | BIO-RAD LABORATORIES, INC. | BUNKER, AMY M | 1684 | §102§103§112 | Non-Final OA | 46d overdue | Pending | Apr 26, 2022 |
| 17563385 | PLATE IMAGER | Quiver Holdings Inc. | HURST, JONATHAN M | 1799 | §103 | Final Rejection | — | Pending | Dec 28, 2021 |
| 17466309 | DISTINGUISHING RARE VARIATIONS IN A NUCLEIC ACID SEQUENCE FROM A SAMPLE | BIO-RAD LABORATORIES, INC. | YU, TIAN NMN | 1681 | §102§103 | Non-Final OA | 47d | Pending | Sep 03, 2021 |
| 17435697 | SYSTEMS, COMPOSITIONS, AND METHODS FOR TARGET ENTITY DETECTION | Mercy Bioanalytics, Inc. | RAMADAN, OMAR | 1678 | §103Other | Non-Final OA | — | Pending | Sep 01, 2021 |
| 17403811 | CATHETER SYSTEMS AND RELATED METHODS FOR MAPPING, MINIMIZING, AND TREATING CARDIAC FIBRILLATION | University Of Vermont And State Agricultural College | LEE, DAVINA EN-YIN | 3794 | §101§103 | Final Rejection | 1d overdue | Pending | Aug 16, 2021 |
| 17322842 | COMPOSITIONS AND METHODS TO DISINFECT, TREAT AND PREVENT MICROBIAL INFECTIONS | Wiab Water Innovation AB | PHAN, DOAN THI-THUC | 1613 | §102§103§112 | Non-Final OA | — | Pending | May 17, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial86.8% of resolved applications prosecuted by Sullivan & Worcester LLP were allowed, across 615 applications in USPTO records.
4.12 office actions per allowed application on average.
52 pending office actions as of October 2026, for 19 clients, before 46 examiners in 27 art units.
